Journey Strategic Wealth LLC increased its holdings in Relx Plc (NYSE:RELX – Free Report) by 54.7% in the fourth quarter, Holdings Channel reports. The fund owned 8,814 shares of the technology company’s stock after purchasing an additional 3,117 shares during the quarter. Journey Strategic Wealth LLC’s holdings in Relx were worth $400,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in RELX. Marshall Wace LLP bought a new stake in shares of Relx in the 2nd quarter valued at about $312,000. AQR Capital Management LLC bought a new position in Relx in the second quarter worth approximately $433,000. NewEdge Advisors LLC raised its stake in Relx by 143.5% in the second quarter. NewEdge Advisors LLC now owns 30,223 shares of the technology company’s stock worth $1,387,000 after buying an additional 17,809 shares in the last quarter. Cetera Investment Advisers lifted its holdings in Relx by 0.6% during the second quarter. Cetera Investment Advisers now owns 61,005 shares of the technology company’s stock worth $2,799,000 after buying an additional 339 shares during the period. Finally, Sanctuary Advisors LLC bought a new stake in Relx during the 2nd quarter valued at $5,016,000. 15.02% of the stock is currently owned by institutional investors.
Relx Price Performance
Shares of RELX opened at $49.87 on Monday. The company has a 50 day moving average of $47.13 and a two-hundred day moving average of $46.81. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.42 and a current ratio of 0.48. Relx Plc has a twelve month low of $40.25 and a twelve month high of $50.55.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on Relx
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- What to Know About Investing in Penny Stocks
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- Why Are These Companies Considered Blue Chips?
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.